US 11891607
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted A61KA61K31/4535A61K31/565
Quick answer
US patent 11891607 (Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4535, A61K31/565, A61K31/57, A61K31/663